CarbGeM to Present New Products at BIO International Convention 2023 and Accelerate US Expansion.

TOKYO, Japan, May 17, 2023 — CarbGeM Inc. (CEO: Masakazu Nakajima, Headquarters: Tokyo, Japan), a Japan-based startup focused on AI-based diagnostics, today announced that its three products addressing the problem of Antimicrobial Resistance (AMR) will be presented at the BIO International Convention, June 5-8, 2023, in Boston.

Featured products include the Point-of-Care Gram Staining System, PoCGS, and the AI-based smartphone app, BiTTE, which estimates the bacterial species in a Gram-stained sample. Both products are the result of collaborative research with the National Center for Global Health and Medicine and Kobe University.

In addition, a new thin-film transistor (TFT) image sensor that monitors bacterial growth on agar plates and its applications in clinical testing will be presented.

Details of the exhibition.

Monday June 5th to Thursday June 8th

Booth 2577

Boston Convention & Exhibition Center (415 Summer St, Boston, MA 02210)

About CarbGeM Inc.

Through the fusion of biology and digital technology, CarbGeM aims to apply its proprietary AI analysis technology to the field of bacterial infectious diseases. CarbGeM will accelerate industry-academia collaboration with domestic and overseas academia, companies, etc., and contribute to solving the global issue of drug resistance through open innovation.

For more information, please visit the company website at